Cargando…

ODP139 Association between serum soluble (pro)renin receptor level and worsening of cardiac function in hemodialysis patients: A prospective observational study

 : A total of 258 maintenance HD patients were recruited and serum s(P)RR concentration was measured. BACKGROUND: factors in patients who survived (S group) and patients who died (D group) during the 12-month follow-up period and relationships between serum s(P)RR level and changes in cardiac functi...

Descripción completa

Detalles Bibliográficos
Autores principales: Morimoto, Satoshi, Amari, Yoshifumi, Suda, Chikahito, Bokuda, Kanako, Nakajima, Fumitaka, Ichihara, Atsuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624595/
http://dx.doi.org/10.1210/jendso/bvac150.490
_version_ 1784822269391929344
author Morimoto, Satoshi
Amari, Yoshifumi
Suda, Chikahito
Bokuda, Kanako
Nakajima, Fumitaka
Ichihara, Atsuhiro
author_facet Morimoto, Satoshi
Amari, Yoshifumi
Suda, Chikahito
Bokuda, Kanako
Nakajima, Fumitaka
Ichihara, Atsuhiro
author_sort Morimoto, Satoshi
collection PubMed
description  : A total of 258 maintenance HD patients were recruited and serum s(P)RR concentration was measured. BACKGROUND: factors in patients who survived (S group) and patients who died (D group) during the 12-month follow-up period and relationships between serum s(P)RR level and changes in cardiac function during the follow-up period in the S group were investigated. The median serum s(P)RR value at baseline was29.8 ng/ml. Twenty-four patients died during the follow-up period. Cardiothoracic ratio, human atrial natriuretic peptide (hANP), brain natriuretic peptide (BNP), and E over e-prime were significantly higher in the D group. In the S group, changes in hANP or BNP were significantly greater in the higher serum s(P)RR group than in the lower serum s(P)RR group. High serum s(P)RR level was significantly correlated with changes in BNP, independent of other factors. High serum s(P)RR level was associated with increases in BNP, independent of other risk factors, suggesting that an increased expression of (P)RR may be associated with a progression of heart failure in HD patients and that serum s(P)RR concentration could be used as a biomarker for selecting patients requiring intensive care. Presentation: No date and time listed
format Online
Article
Text
id pubmed-9624595
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96245952022-11-14 ODP139 Association between serum soluble (pro)renin receptor level and worsening of cardiac function in hemodialysis patients: A prospective observational study Morimoto, Satoshi Amari, Yoshifumi Suda, Chikahito Bokuda, Kanako Nakajima, Fumitaka Ichihara, Atsuhiro J Endocr Soc Cardiovascular Endocrinology  : A total of 258 maintenance HD patients were recruited and serum s(P)RR concentration was measured. BACKGROUND: factors in patients who survived (S group) and patients who died (D group) during the 12-month follow-up period and relationships between serum s(P)RR level and changes in cardiac function during the follow-up period in the S group were investigated. The median serum s(P)RR value at baseline was29.8 ng/ml. Twenty-four patients died during the follow-up period. Cardiothoracic ratio, human atrial natriuretic peptide (hANP), brain natriuretic peptide (BNP), and E over e-prime were significantly higher in the D group. In the S group, changes in hANP or BNP were significantly greater in the higher serum s(P)RR group than in the lower serum s(P)RR group. High serum s(P)RR level was significantly correlated with changes in BNP, independent of other factors. High serum s(P)RR level was associated with increases in BNP, independent of other risk factors, suggesting that an increased expression of (P)RR may be associated with a progression of heart failure in HD patients and that serum s(P)RR concentration could be used as a biomarker for selecting patients requiring intensive care. Presentation: No date and time listed Oxford University Press 2022-11-01 /pmc/articles/PMC9624595/ http://dx.doi.org/10.1210/jendso/bvac150.490 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Cardiovascular Endocrinology
Morimoto, Satoshi
Amari, Yoshifumi
Suda, Chikahito
Bokuda, Kanako
Nakajima, Fumitaka
Ichihara, Atsuhiro
ODP139 Association between serum soluble (pro)renin receptor level and worsening of cardiac function in hemodialysis patients: A prospective observational study
title ODP139 Association between serum soluble (pro)renin receptor level and worsening of cardiac function in hemodialysis patients: A prospective observational study
title_full ODP139 Association between serum soluble (pro)renin receptor level and worsening of cardiac function in hemodialysis patients: A prospective observational study
title_fullStr ODP139 Association between serum soluble (pro)renin receptor level and worsening of cardiac function in hemodialysis patients: A prospective observational study
title_full_unstemmed ODP139 Association between serum soluble (pro)renin receptor level and worsening of cardiac function in hemodialysis patients: A prospective observational study
title_short ODP139 Association between serum soluble (pro)renin receptor level and worsening of cardiac function in hemodialysis patients: A prospective observational study
title_sort odp139 association between serum soluble (pro)renin receptor level and worsening of cardiac function in hemodialysis patients: a prospective observational study
topic Cardiovascular Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624595/
http://dx.doi.org/10.1210/jendso/bvac150.490
work_keys_str_mv AT morimotosatoshi odp139associationbetweenserumsolubleproreninreceptorlevelandworseningofcardiacfunctioninhemodialysispatientsaprospectiveobservationalstudy
AT amariyoshifumi odp139associationbetweenserumsolubleproreninreceptorlevelandworseningofcardiacfunctioninhemodialysispatientsaprospectiveobservationalstudy
AT sudachikahito odp139associationbetweenserumsolubleproreninreceptorlevelandworseningofcardiacfunctioninhemodialysispatientsaprospectiveobservationalstudy
AT bokudakanako odp139associationbetweenserumsolubleproreninreceptorlevelandworseningofcardiacfunctioninhemodialysispatientsaprospectiveobservationalstudy
AT nakajimafumitaka odp139associationbetweenserumsolubleproreninreceptorlevelandworseningofcardiacfunctioninhemodialysispatientsaprospectiveobservationalstudy
AT ichiharaatsuhiro odp139associationbetweenserumsolubleproreninreceptorlevelandworseningofcardiacfunctioninhemodialysispatientsaprospectiveobservationalstudy